000 | 01369 a2200373 4500 | ||
---|---|---|---|
005 | 20250518035719.0 | ||
264 | 0 | _c20190911 | |
008 | 201909s 0 0 eng d | ||
022 | _a1179-1918 | ||
024 | 7 |
_a10.1007/s40261-019-00790-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCiruelos, Eva | |
245 | 0 | 0 |
_aMaintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept. _h[electronic resource] |
260 |
_bClinical drug investigation _cJul 2019 |
||
300 |
_a595-606 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBevacizumab _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCapecitabine _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aPérez-García, José Manuel | |
700 | 1 | _aGavilá, Joaquín | |
700 | 1 | _aRodríguez, Analía | |
700 | 1 | _ade la Haba-Rodriguez, Juan | |
773 | 0 |
_tClinical drug investigation _gvol. 39 _gno. 7 _gp. 595-606 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40261-019-00790-9 _zAvailable from publisher's website |
999 |
_c29656341 _d29656341 |